Find comprehensive information on Implantable Cardioverter-Defibrillator (ICD) diagnosis, including clinical documentation requirements, medical coding guidelines, and healthcare best practices. Learn about ICD insertion, management, and follow-up care. Explore relevant medical codes like ICD-10-PCS and CPT codes for ICD procedures. This resource offers guidance for physicians, coders, and other healthcare professionals seeking accurate and up-to-date information on Implantable Cardioverter-Defibrillators.
Electronic device implanted to detect and correct life-threatening heart rhythms (arrhythmias).
Syncope, palpitations, dizziness, or prior cardiac arrest. ECG may show ventricular tachycardia or fibrillation.
Shock therapy for ventricular fibrillation and tachycardia. Anti-tachycardia pacing for slower rhythms. Device monitoring.
Complete code families applicable to Z95.810
| Description | When to use |
|---|---|
| Implantable Cardioverter-Defibrillator | For patients with an implanted ICD for arrhythmia prevention, including single and dual chamber devices. |
| Cardiac Arrhythmia | Use for any irregular heartbeat, including atrial fibrillation, ventricular tachycardia, bradycardia, etc. Specify type if known. |
| Syncope and Collapse | Code when a patient experiences a transient loss of consciousness, often related to cardiac causes like arrhythmias. |
Inaccurate coding for ICD lead placement (e.g., atrial, ventricular) can impact DRG assignment and reimbursement.
Lack of documentation specifying single or dual chamber ICD, impacting accurate code selection and payment.
Coding confusion between initial implant and replacement procedures can lead to claim denials or underpayments.
ICD-10-PCS: Verify code matches implant procedure (e.g., 0JH...
ICD-10-CM: Document primary indication for ICD (e.g., I49.0)
Hx: Confirm eligibility criteria met (EF, prior MI, etc.)
Device data: Record model serial number in chart
Patient presents for implantable cardioverter-defibrillator (ICD) management. The patient's primary diagnosis is [Specific underlying heart condition, e.g., heart failure, ischemic cardiomyopathy, nonischemic cardiomyopathy, ventricular arrhythmia, sudden cardiac arrest, Brugada syndrome, Long QT syndrome, hypertrophic cardiomyopathy]. Current indications for ICD therapy include [Specific indication, e.g., primary prevention of sudden cardiac death, secondary prevention of sudden cardiac death, symptomatic ventricular tachycardia, ventricular fibrillation]. Device interrogation reveals [Specific device findings, e.g., stable lead impedances, appropriate sensing and pacing thresholds, battery life of [duration], no evidence of inappropriate shocks or lead malfunction]. Patient reports [Patient-reported symptoms related to device or underlying condition, e.g., no palpitations, no syncope, no shocks delivered, no chest pain]. Physical examination reveals [Relevant physical findings, e.g., stable vital signs, regular heart rhythm, normal heart sounds, no edema]. Medications include [List of current medications including antiarrhythmics, beta-blockers, ACE inhibitors, etc.]. Plan of care includes continuation of current medications, optimization of heart failure therapy if applicable, patient education regarding device function and potential complications, and scheduled ICD follow-up in [ timeframe, e.g., 3 months, 6 months]. ICD coding includes [Relevant ICD-10 codes, e.g., Z45.01, Z45.02, I49.5, plus code(s) for underlying cardiac condition]. Medical billing will reflect device interrogation and management. This documentation supports medical necessity for ICD therapy and ongoing monitoring.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.